BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1698898)

  • 1. [Central and peripheral type small cell carcinoma of the lung--histologic, immunohistochemical, and clinical analyses].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jul; 38(7):1112-7. PubMed ID: 1698898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large cell carcinoma of the lung--ultrastructural and immunohistochemical studies.
    Kodama T; Shimosato Y; Koide T; Watanabe S; Teshima S
    Jpn J Clin Oncol; 1985 Jun; 15(2):431-41. PubMed ID: 2410641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological findings and prognosis in 202 patients with small cell lung cancer].
    Huang ZY; Li HZ; Xu PQ
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):38-41. PubMed ID: 2843333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cytoskeletal proteins in small cell lung carcinoma.
    Hlozánková M; Lukás Z; Viklický V
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
    Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical findings in resected lung cancer].
    Komatsu H; Tamura A; Yoneda R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Oct; 29(10):1234-8. PubMed ID: 1753499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtypes of small cell carcinoma of the lung: morphometric, ultrastructural, and immunohistochemical analyses.
    Nomori H; Shimosato Y; Kodama T; Morinaga S; Nakajima T; Watanabe S
    Hum Pathol; 1986 Jun; 17(6):604-13. PubMed ID: 3011640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-100 protein in human lung neuroendocrine neoplasms. Immunohistochemical study of 14 cases and review of the literature.
    Barbareschi M; Mauri MF; Muscara M; Mauri FA; Lo Re V
    Histol Histopathol; 1987 Apr; 2(2):185-92. PubMed ID: 2856552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases.
    Matsui K; Kitagawa M; Miwa A; Kuroda Y; Tsuji M
    Am J Gastroenterol; 1991 Sep; 86(9):1167-75. PubMed ID: 1715667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
    Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
    Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic changes in small cell lung carcinoma after treatment.
    Fushimi H; Kikui M; Morino H; Yamamoto S; Tateishi R; Wada A; Aozasa K; Kotoh K
    Cancer; 1996 Jan; 77(2):278-83. PubMed ID: 8625235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
    Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
    Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cytokeratin and neuron-specific enolase in small cell carcinomas of the lung.
    Kitinya JN; Kingo M; Tanaka K
    Histol Histopathol; 1987 Oct; 2(4):333-43. PubMed ID: 2485219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
    Popper H; Wirnsberger G; Hoefler H; Denk H
    Cancer Detect Prev; 1987; 10(3-4):167-74. PubMed ID: 2436780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
    Maruno K
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.